<!DOCTYPE HTML>
<html lang="en">
<head>
	<meta charset="UTF-8">
	<title>VIKHI</title>
	<link rel="stylesheet" href="css/font-awesome/css/font-awesome.min.css" />

	<link rel="stylesheet" href="css/fonts/stylesheet.css" />
	<link rel="stylesheet" href="css/fonts/fonts.css" />
	<link rel="stylesheet" href="css/bootstrap/bootstrap.min.css" />
	<link rel="stylesheet" href="css/animat/animate.min.css" />
	<link rel="stylesheet" href="css/fancybox/jquery.fancybox.css" />
	<link rel="stylesheet" href="css/nivo-lightbox/nivo-lightbox.css" />
	<link rel="stylesheet" href="css/themes/default/default.css" />
	<link rel="stylesheet" href="css/owl-carousel/owl.carousel.css" />
	<link rel="stylesheet" href="css/owl-carousel/owl.theme.css" />
	<link rel="stylesheet" href="css/owl-carousel/owl.transitions.css">
	<link rel="stylesheet" href="css/style.css" />
	<link rel="stylesheet" href="css/responsive.css" />
	<link href="https://fonts.googleapis.com/css?family=Montserrat|Source+Sans+Pro" rel="stylesheet">
</head>
<body>

	<div class='preloader'><div class='loaded'>&nbsp;</div></div>

	<header id="home" class="header">
		<div class="main_menu_bg navbar-fixed-top">
			<div class="container">
				<div class="row">
					<div class="nave_menu">
					<nav class="navbar navbar-default">
					  <div class="container-fluid">
						<div class="navbar-header">
						  <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false">
						  </button>
						  <a class="navbar-brand" href="index.html">
							<div class="logo">
								<img src="images/vikhiLOGOsm.png" alt="" height="30"/>
							</div>
						  </a>
						</div>

						<div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1">

						  <ul class="nav navbar-nav navbar-right">
							<li><a href="aspectos.html">1. General aspects</a></li>
							<li><a href="recomendaciones.html">2. Recommendations</a></li>
							<li class="active"><a href="toxicidad00.html">3. Toxicities</a></li>
						  </ul>
						</div>
					  </div>
					</nav>
					</div>
				</div>

			</div>

		</div>
	</header>



	<section class="banner">
		<div class="container">
			<div class="row">
				<div class="main_banner_area text-center">
					<div class="col-md-12 col-sm-12">
						<div class="single_banner_text wow zoomIn" data-wow-duration="1s">
							<h2>Toxicities</h2>
							<br>
							<div class="separator"></div>
							<h5>BASIC COURSE IN IMMUNOTHERAPY</h5>


						</div>
					</div>
				</div>
			</div>
		</div>
	</section>



	<section id="31" class="franja">
	 <div class="overlay_franja">
		 <div class="container">
			 <div class="row">
				 <div class="col-md-12 col-sm-12 col-xs-12">
					 <div class="main_franja_content text-center wow fadeIn" data-wow-duration="2s">
						 <h2>3<span class="negrita">.1</span> GASTROINTESTINAL TOXICITY <span class="negrita">-</span> ENTEROCOLITIS</h2>
						 <br> <img src="images/ORGANOstomachSM.png" alt="" height="50px"/>
					 </div>
				 </div>
			 </div>
		 </div>
	 </div>
 </section>


	<section class="texto">
		<div class="container">
			<div class="row">
				<div class="parrafo wow zoomIn" data-wow-duration="0.5s">
					<h2>Introduction</h2>
					<br>
					<p>Enterocolitis which presents as diarrhoea is one of the most common immune-mediated adverse effects (imAEs).</p>
					<br>
					<p>They are described in 5-44% of patients treated with inhibitors of immune checkpoints, especially with anti-CTLA4 (Cytotoxic T-Lymphocyte Antigen 4) drugs. Diarrhoea is the clinical manifestation of inflammation of the colon walls by infiltration of neutrophils and/or lymphocytes.</p>
					<br>
					<p>Early diagnosis and treatment of immune-mediated enterocolitis is essential for good clinical progress with satisfactory results. Early administration of corticosteroids can prevent deleterious and potentially life-threatening adverse effects, such as intestinal perforation.</p>
					<br>
					<p>Currently there is no premedication indicated for immune-mediated diarrhoea. It is important that the patient is well informed of the risks related to the immunotherapy drugs that are administered, as well as the importance of contacting medical personnel in the event of diarrhoeic stools (or intestinal transit disorders) from the start of treatment.</p>
					<br>
					<p>Health education is the best for the early diagnosis of enterocolitis, as well as the recording of the number and volume of stools, date and related symptoms.</p>
					<br>

				</div>
			</div>
		</div>
	</section>


			<section class="counterUp">
				<div class="counter_overlay">
				<div class="container">
				<div class="row">
					<div class="main_counter_content text-center">
					<div class="col-md-12 col-sm-12 col-xs-12">



					<img src="images/diagnostico.png" alt="" height="40px"/> <br><br>
					<h2>Diagnosis</h2>
					<br> <br>
					<p>Increased number of normal stools and changes in the characteristics and consistency of stools in comparison to what is normal</p>
					<br>
					<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> Nocturnal diarrhoea or faecal incontinence</p>
					<br>
					<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> Blood or mucus in stools</p>
					<br>
					<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> Colic-type abdominal pain, gas</p>
					<br>
					<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> Asthenia, fever, generalised weakness and dehydration symptoms given the water-electrolyte loss.</p>
				</div>
			</div>

				</div>
			</div>
		</div>
	</section>


		<section class="texto">
			<div class="container">
				<div class="row">
					<div class="parrafo wow zoomIn" data-wow-duration="0.5s">
						<h2>Incidence</h2>
					<br>
					<p>Associated with CTLA-4 inhibitors: 30-44% with time to onset in the first 5 weeks after the first treatment dose.</p>
					<br>
					<p>Associated with PD-1 or PLD-1 inhibitors: 5-20%.</p>
					<br> <br><br> <br>
					<h2>Therapeutic management</h2>
					<br>

					<div class="marco wow fadeIn">
					<p><span class="decorado">&nbsp;GRADE 1:&nbsp;</span> <span class="turquesa">Increase in stool number &lt; 4 per day; mild increase in bowel movements with respect to baseline</span>.</p>
					<p>Does not require discontinuation of the drug. Dietary control Increased water-electrolyte support.</p>
					<br>
					<p>Starting Loperamide 4 mg (1st dose) and after each episode of diarrhoea 2mg (up to a maximum of 16 mg daily for 3 days)</p>
					<br>
					<p>If it is not resolved after 3 days, treat as a <span class="turquesa">GRADE 2</span>.</p>
					</div>


					<br>

					<div class="marco wow fadeIn">
					<p><span class="decorado">&nbsp;GRADE 2:&nbsp;</span> <span class="turquesa">Increased number of stools of 4-6 faeces per day; moderate increase in bowel movements with respect to baseline</span>.</p>
					<br>
					<p>Discontinuation of the drug. Same dietary-hygiene-therapeutic measures as for GRADE 1. Analysis of stool cultures, C. difficile and parasite toxins. Consult digestive system specialist. Consider colonoscopy +/- biopsy.</p>
					<br>
					<p>Starting corticosteroid therapy: </p>
					<br>
					<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> Prednisolone 1 mg/kg oraly for 3 days (maximum 60 mg), reducing to 20 mg and maintain for 1-2 weeks</p>
					<br>
					<p class="centrado">or</p>
					<br>
					<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> Methylprednisolone 1 mg/kg/day intravenously until GRADE 1, reduce dose and start prednisolone 1 mg/kg orally, reducing the dose over a period of 6 weeks.</p>
					<br>
					<p>If it is not resolved/improved to GRADE 1 after 3 days, treat as GRADE 3-4.</p>
					</div>

					<br>

					<div class="marco wow fadeIn">
					<p><span class="decorado">&nbsp;GRADE 3:&nbsp;</span> <span class="turquesa">Increase in stool number &gt; 7 per day; faecal incontinence; indication for hospitalisation; severe increase in bowel movements with respect to baseline</span>.</p>
					<br>
					<p>Consider permanent discontinuation of the drug. Same dietary-hygiene-therapeutic measures as for <span class="turquesa">GRADE 2</span>. Hospitalisation and water-electrolyte support via IV route. </p>
					<br>
					<p>Starting corticosteroids with Methylprednisolone 4 mg/kg/day intravenously until <span class="turquesa">GRADE 1</span>, then reduce dose and start prednisolone 1 mg/kg, reducing the dose over a period of 6 weeks.</p>
					<br>
					<p>If not resolved/improved to <span class="turquesa">GRADE 1</span> after 3 days<span class="turquesa">:</span></p>
					<br>
					<p><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> Infliximab 5 mg/kg intravenously</p>
					<br>
					<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> Consider Octreotide 100 µg subcutaneously, up to 200 µg subcutaneously if there is a high loss of fluid (blood volume) due to diarrhoea.</p>
					<br>
					<p>If the diarrhoea persists and/or there is risk of perforation, consider colectomy.</p>
					</div>

					<br>

					<div class="marco wow fadeIn">
					<p><span class="decorado">&nbsp;GRADE 4:&nbsp;</span> <span class="turquesa">Dangerous and potentially life-threatening consequences; require urgent intervention</span>.</p>
					<br>
					<p>Same guidelines as <span class="turquesa">GRADE 3</span>.</p>
					</div>
					<br>

					<div class="marco wow fadeIn">
					<p><span class="decorado">&nbsp;GRADE 5:&nbsp;</span> <span class="turquesa">Death</span>.</p>
					</div>
					<br>



				</div>
			</div>
		</div>
	</section>

	<section class="counterUp">
		<div class="counter_overlay">
			<div class="container">
				<div class="row">
					<div class="main_counter_content text-center">
						<div class="col-md-12 col-sm-12 col-xs-12">


							<h2>CLINICAL CASE</h2>
							<br> <img src="images/pacienteICON.png" alt="" height="40px"/> <br> <br> <br>
							<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> A 46-year-old patient diagnosed in May 2017 with uveal melanoma in the right eye, having undergone enucleation on 02/03/2016. The histological result was melanoma with diffuse choroid involvement 18 mm in diameter with 1.5 mm in thickness; epithelioid type with necrosis (20%) and no inflammatory infiltrate. Ciliary body invasion At 12 months, recurrence of the disease was seen in the liver.</p>
							<br>
							<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> Chemotherapy started with Fotemustine 100 mg/m2 regimen, receiving 3 induction doses, with PD in the liver.</p>
							<br>
							<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> In September 2018 started Ipilimumab 3 mg/kg/ 3 weeks.</p>
							<br> <br> <img src="images/medicinas.png" alt="" height="40px"/> <br><br>
							<p><span class="negrita">At 2 months after the start of Ipilimumab, the patient was:</span></p>
							<br>

							<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> Haemodynamically stable, afebrile.</p>
							<br>
							<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> Colic-like abdominal pain with diarrhoeic stools 4 times a day, with no pathological products. Globular abdomen, increased peristalsis and painful abdominal decompression. Not hard abdomen.</p>
							<br>
							<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> Analysis highlights leukocytosis with no left shift, with an increase in normal levels of acute-phase reactants (CRP, ESR).</p>
							<br>
							<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> Abdomen x-ray: air luminogram in colon frame, with distension of small intestine loops, located in the mesogastrium.</p>
							<br><br>




							<div class="marcoOSCURO wow fadeIn">

							<form>
							<br> <br> <br>
							<h2>Given these findings, what grade would be given to this clinical picture?</h2>
							<br> <br> <br> <br>
							<label class="container">GRADE 1
								<input type="radio" name="pregunta1" id="p2">
								<span class="checkmark"></span>
							</label>
							<br>
							<label class="container">GRADE 2
								<input type="radio" name="pregunta1" id="p1">
								<span class="checkmark"></span>
							</label>
							<br>
							<label class="container">GRADE 3
								<input type="radio" name="pregunta1" id="p3">
								<span class="checkmark"></span>
							</label>
							</form>


							<div class="pregunta wow fadeIn" data-wow-duration="1s">
								<a href="#"><img onclick="resultado();return false;" src="images/profesora.png" alt="" height="90px"/></a>
							</div>


								<div id="flotante" style="display:none;">
									<br><br><h2>Correct!</h2>
									<br>
									<p>The patient has a GRADE 2 diarrhoea (Increase in the number of stools from 4-6 per day); therefore the following took place: Discontinuation of the drug. Analysis of stool cultures, C. difficile and parasite toxins which were negative. Dietary control Increased water-electrolyte support. Loperamide started at 4 mg (1st dose) and 2 mg after each episode of diarrhoea (up to a maximum of 16 mg daily for 3 days), and Prednisolone started at 1 mg/kg, administered orally for 3 days (maximum 60 mg), reducing the dose to 20 mg with symptom improving on 2nd day, so it was possible to reduce the dose to nothing over the following 2-3 weeks.</p></p>

								</div>
								<div id="flotanteIncorrecto" style="display:none;">
									<br><br>
									<h2>This is not correct. Try again :)</h2>

								</div>


							</div>




							<br>

							<div class="contorno wow fadeIn">
							<h2>REMEMBER <span class="negrita">:</span></h2>
							<br>
							<p><span class="negrita">•</span> It is important that the patient is well informed about the risks associated with the immunotherapy drugs administered, as well as the importance of contacting medical personnel in the event of diarrhoeic stools from the start of treatment. Health education is the best intervention for the early diagnosis of enterocolitis, as well as recording the number and volume of stools, date and related symptoms.</span></p>
							</div>


						</div>
					</div>
				</div>
			</div>
		</div>
	</section>



	<section>
	 <div class="container">
		 <div class="row">

			 <div class="wedo_content_area">

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contornoActivo wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad01.html"><h4 class="gris">3.1 GASTROINTESTINAL TOX.</h4></a>
						 </div>
					 </div>
				 </div>

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contorno wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad02.html"><h4>3<span class="turquesa">.2</span> PULMONARY TOXICITY</h4></a>
						 </div>
					 </div>
				 </div>

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contorno wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad03.html"><h4>3<span class="turquesa">.3</span> RENAL TOXICITY</h4></a>
						 </div>
					 </div>
				 </div>

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contorno wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad04.html"><h4>3<span class="turquesa">.4</span> LIVER TOXICITY</h4></a>
						 </div>
					 </div>
				 </div>

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contorno wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad05.html"><h4>3<span class="turquesa">.5</span> ENDOCRINE TOXICITY</h4></a>
						 </div>
					 </div>
				 </div>

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contorno wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad06.html"><h4>3<span class="turquesa">.6</span> CUTANEOUS TOXICITY</h4></a>
						 </div>
					 </div>
				 </div>

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contorno wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad07.html"><h4>3<span class="turquesa">.7</span> NEUROLOGICAL TOXICITY</h4></a>
						 </div>
					 </div>
				 </div>

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contorno wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad08.html"><h4>3<span class="turquesa">.8</span> OTHER TOXICITIES</h4></a>
						 </div>
					 </div>
				 </div>
			 </div>
		 </div>
	 </div>
	</section>


	<footer id="footer" class="footer">
		<div class="container">
			<div class="row">
				<div class="main_footer text-center wow zoomIn" data-wow-duration="1s">
					<p class="centrado"><a href="https://www.e-oncologia.org/"><img src="images/LOGOeonco.png" alt="" height="22px"/></a></p>
				</div>
			</div>
		</div>
	</footer>

	<!-- STRAT SCROLL TO TOP -->

	<div class="scrollup">
		<a href="#"><img src="images/up.png" alt=""/></a>
	</div>






	<script type="text/javascript" src="js/jquery/jquery.js"></script>

	<script type="text/javascript" src="js/script.js"></script>

	<script type="text/javascript" src="js/bootstrap/bootstrap.min.js"></script>

	<script type="text/javascript" src="js/fancybox/jquery.fancybox.pack.js"></script>

	<script type="text/javascript" src="js/nivo-lightbox/nivo-lightbox.min.js"></script>

	<script type="text/javascript" src="js/owl-carousel/owl.carousel.min.js"></script>

	<script type="text/javascript" src="js/test.js"></script>




	<script type="text/javascript" src="js/jquery-easing/jquery.easing.1.3.js"></script>
	<script type="text/javascript" src="js/wow/wow.min.js"></script>
	<!--<script type="text/javascript" src="js/counterup/counterup.min.js"></script>-->

	<!--<script src="http://cdnjs.cloudflare.com/ajax/libs/waypoints/2.0.3/waypoints.min.js"></script>-->
	<!--<script type="text/javascript" src="js/counterup/jquery.counterup.min.js"></script>-->


	<script type="text/javascript" src="js/isotop/isotope.min.js"></script>
	<script type="text/javascript" src="js/isotop/isotop.function.js"></script>

	<script type="text/javascript" src="js/masonry/masonry.min.js"></script>

	<script type="text/javascript" src="js/mixitup/jquery.mixitup.min.js"></script>
	<script type="text/javascript" src="js/masonry/masonry.pkgd.min.js"></script>
</body>
</html>
